LAUREN PATTIS: Open Payments
NPI 1487137022 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,948 in 262 payments from 21 companies in 2025. Trend: 2023 $2,174 · 2024 $3,106 · 2025 $3,948
Food & beverage: $3,848Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 72 | $940 |
| Janssen Biotech, Inc. | 20 | $337 |
| GENZYME CORPORATION | 10 | $297 |
| Galderma Laboratories, L.P. | 20 | $279 |
| Incyte Corporation | 18 | $252 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $240 |
| PFIZER INC. | 14 | $231 |
| E.R. Squibb & Sons, L.L.C. | 17 | $193 |
| UCB, Inc. | 13 | $193 |
| Regeneron Healthcare Solutions, Inc. | 16 | $189 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, RINVOQ, OPZELURA, CIBINQO, Sotyktu, Bimzelx.
Industry payments across NJ — which companies pay providers there.
